{"transactions":[{"id":948759,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-01-06T21:16:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":1962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1962,"derivative":{"exercise_price":772.76,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":1962},"source":{"system":"sec-edgar","filing":"0001225471-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000122547126000002/edgardoc.xml","form_type":"4"}},{"id":948758,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T21:16:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":31007,"source":{"system":"sec-edgar","filing":"0001225471-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000122547126000002/edgardoc.xml","form_type":"4"}},{"id":956807,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-12-31T22:05:40.000Z","date":"2025-12-30","kind":"exercise","planned":false,"acquired":false,"shares":9212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":520.01,"expiration_date":"2026-01-04","underlying":"Common Stock","underlying_shares":9212},"source":{"system":"sec-edgar","filing":"0001225471-25-000006","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000122547125000006/edgardoc.xml","form_type":"4"}},{"id":956806,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-31T22:05:40.000Z","date":"2025-12-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":6188,"price":774.03,"value":4789697.64,"ownership":{"direct":true},"balance_after":30852,"source":{"system":"sec-edgar","filing":"0001225471-25-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000122547125000006/edgardoc.xml","form_type":"4"}},{"id":956805,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-31T22:05:40.000Z","date":"2025-12-30","kind":"exercise","planned":false,"acquired":true,"shares":9212,"price":520.01,"value":4790332.12,"ownership":{"direct":true},"balance_after":37040,"source":{"system":"sec-edgar","filing":"0001225471-25-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000122547125000006/edgardoc.xml","form_type":"4"}},{"id":1317182,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-01-03T21:02:28.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":1958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1958,"derivative":{"exercise_price":719.37,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":1958},"source":{"system":"sec-edgar","filing":"0001968202-25-000001","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820225000001/edgardoc.xml","form_type":"4"}},{"id":1317181,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-01-03T21:02:28.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":3338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":413.33,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":3338},"source":{"system":"sec-edgar","filing":"0001968202-25-000001","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820225000001/edgardoc.xml","form_type":"4"}},{"id":1317180,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T21:02:28.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":27828,"source":{"system":"sec-edgar","filing":"0001968202-25-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820225000001/edgardoc.xml","form_type":"4"}},{"id":1317179,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T21:02:28.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1948,"price":708.19,"value":1379554.12,"ownership":{"direct":true},"balance_after":27662,"source":{"system":"sec-edgar","filing":"0001968202-25-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820225000001/edgardoc.xml","form_type":"4"}},{"id":1317178,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T21:02:28.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":3338,"price":413.33,"value":1379695.54,"ownership":{"direct":true},"balance_after":29610,"source":{"system":"sec-edgar","filing":"0001968202-25-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820225000001/edgardoc.xml","form_type":"4"}},{"id":1414688,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T20:01:57.000Z","date":"2024-09-04","kind":"gift","planned":false,"acquired":false,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26272,"source":{"system":"sec-edgar","filing":"0001968202-24-000126","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000126/edgardoc.xml","form_type":"4"}},{"id":1526867,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-05-06T20:20:02.000Z","date":"2024-05-03","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":3338,"derivative":{"exercise_price":413.33,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001883850-24-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000020/edgardoc.xml","form_type":"4"}},{"id":1526866,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-06T20:20:02.000Z","date":"2024-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":877,"price":942.53,"value":826598.81,"ownership":{"direct":true},"balance_after":27472,"source":{"system":"sec-edgar","filing":"0001883850-24-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000020/edgardoc.xml","form_type":"4"}},{"id":1526865,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-06T20:20:02.000Z","date":"2024-05-03","kind":"exercise","planned":false,"acquired":true,"shares":2000,"price":413.33,"value":826660.0,"ownership":{"direct":true},"balance_after":28349,"source":{"system":"sec-edgar","filing":"0001883850-24-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000020/edgardoc.xml","form_type":"4"}},{"id":1613536,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-02-28T21:04:19.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":5338,"derivative":{"exercise_price":413.33,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001968202-24-000079","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000079/edgardoc.xml","form_type":"4"}},{"id":1613535,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T21:04:19.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":500,"price":995,"value":497500.0,"ownership":{"direct":true},"balance_after":26349,"source":{"system":"sec-edgar","filing":"0001968202-24-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000079/edgardoc.xml","form_type":"4"}},{"id":1613534,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T21:04:19.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":500,"price":413.33,"value":206665.0,"ownership":{"direct":true},"balance_after":26849,"source":{"system":"sec-edgar","filing":"0001968202-24-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000079/edgardoc.xml","form_type":"4"}},{"id":1613533,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T21:04:19.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":500,"price":990,"value":495000.0,"ownership":{"direct":true},"balance_after":26349,"source":{"system":"sec-edgar","filing":"0001968202-24-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000079/edgardoc.xml","form_type":"4"}},{"id":1613532,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T21:04:19.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":500,"price":413.33,"value":206665.0,"ownership":{"direct":true},"balance_after":26849,"source":{"system":"sec-edgar","filing":"0001968202-24-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000079/edgardoc.xml","form_type":"4"}},{"id":1620738,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-02-26T21:07:25.000Z","date":"2024-02-23","kind":"exercise","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":6338,"derivative":{"exercise_price":413.33,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001968202-24-000072","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000072/edgardoc.xml","form_type":"4"}},{"id":1620737,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-02-26T21:07:25.000Z","date":"2024-02-22","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":6838,"derivative":{"exercise_price":413.33,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001968202-24-000072","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000072/edgardoc.xml","form_type":"4"}},{"id":1620736,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-26T21:07:25.000Z","date":"2024-02-23","kind":"sale","planned":false,"acquired":false,"shares":500,"price":985,"value":492500.0,"ownership":{"direct":true},"balance_after":26349,"source":{"system":"sec-edgar","filing":"0001968202-24-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000072/edgardoc.xml","form_type":"4"}},{"id":1620735,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-26T21:07:25.000Z","date":"2024-02-23","kind":"exercise","planned":false,"acquired":true,"shares":500,"price":413.33,"value":206665.0,"ownership":{"direct":true},"balance_after":26849,"source":{"system":"sec-edgar","filing":"0001968202-24-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000072/edgardoc.xml","form_type":"4"}},{"id":1620734,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-26T21:07:25.000Z","date":"2024-02-22","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":960,"value":960000.0,"ownership":{"direct":true},"balance_after":26349,"source":{"system":"sec-edgar","filing":"0001968202-24-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000072/edgardoc.xml","form_type":"4"}},{"id":1620733,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-26T21:07:25.000Z","date":"2024-02-22","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":413.33,"value":413330.0,"ownership":{"direct":true},"balance_after":27349,"source":{"system":"sec-edgar","filing":"0001968202-24-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000072/edgardoc.xml","form_type":"4"}},{"id":1620732,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-26T21:07:25.000Z","date":"2024-02-22","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":965,"value":965000.0,"ownership":{"direct":true},"balance_after":26349,"source":{"system":"sec-edgar","filing":"0001968202-24-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000072/edgardoc.xml","form_type":"4"}},{"id":1620731,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-26T21:07:25.000Z","date":"2024-02-22","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":413.33,"value":413330.0,"ownership":{"direct":true},"balance_after":27349,"source":{"system":"sec-edgar","filing":"0001968202-24-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000072/edgardoc.xml","form_type":"4"}},{"id":1620730,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-26T21:07:25.000Z","date":"2024-02-22","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":970,"value":970000.0,"ownership":{"direct":true},"balance_after":26349,"source":{"system":"sec-edgar","filing":"0001968202-24-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000072/edgardoc.xml","form_type":"4"}},{"id":1620729,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-26T21:07:25.000Z","date":"2024-02-22","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":413.33,"value":413330.0,"ownership":{"direct":true},"balance_after":27349,"source":{"system":"sec-edgar","filing":"0001968202-24-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000072/edgardoc.xml","form_type":"4"}},{"id":1650341,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-02-12T21:02:31.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":9838,"derivative":{"exercise_price":413.33,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001968202-24-000062","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000062/edgardoc.xml","form_type":"4"}},{"id":1650340,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-02-12T21:02:31.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":10338,"derivative":{"exercise_price":413.33,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001968202-24-000062","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000062/edgardoc.xml","form_type":"4"}},{"id":1650339,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T21:02:31.000Z","date":"2024-02-09","kind":"sale","planned":false,"acquired":false,"shares":500,"price":955,"value":477500.0,"ownership":{"direct":true},"balance_after":26349,"source":{"system":"sec-edgar","filing":"0001968202-24-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000062/edgardoc.xml","form_type":"4"}},{"id":1650338,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T21:02:31.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":500,"price":413.33,"value":206665.0,"ownership":{"direct":true},"balance_after":26849,"source":{"system":"sec-edgar","filing":"0001968202-24-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000062/edgardoc.xml","form_type":"4"}},{"id":1650337,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T21:02:31.000Z","date":"2024-02-08","kind":"sale","planned":false,"acquired":false,"shares":500,"price":945,"value":472500.0,"ownership":{"direct":true},"balance_after":26349,"source":{"system":"sec-edgar","filing":"0001968202-24-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000062/edgardoc.xml","form_type":"4"}},{"id":1650336,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T21:02:31.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":500,"price":413.33,"value":206665.0,"ownership":{"direct":true},"balance_after":26849,"source":{"system":"sec-edgar","filing":"0001968202-24-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000062/edgardoc.xml","form_type":"4"}},{"id":1689442,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-01-04T21:07:50.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":1607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1607,"derivative":{"exercise_price":888.34,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":1607},"source":{"system":"sec-edgar","filing":"0001968202-24-000024","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000024/edgardoc.xml","form_type":"4"}},{"id":1689441,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:07:50.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":26349,"source":{"system":"sec-edgar","filing":"0001968202-24-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000024/edgardoc.xml","form_type":"4"}},{"id":2064239,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-01-05T21:19:47.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1929,"derivative":{"exercise_price":725.89,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":1929},"source":{"system":"sec-edgar","filing":"0001883850-23-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000016/edgardoc.xml","form_type":"4"}},{"id":2064238,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T21:19:47.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":26214,"source":{"system":"sec-edgar","filing":"0001883850-23-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000016/edgardoc.xml","form_type":"4"}},{"id":2367051,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-01T21:03:13.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":1000,"price":617,"value":617000.0,"ownership":{"direct":true},"balance_after":26049,"source":{"system":"sec-edgar","filing":"0001883850-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000014/edgardoc.xml","form_type":"4"}},{"id":2367050,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-01T21:03:13.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":1000,"price":614,"value":614000.0,"ownership":{"direct":true},"balance_after":27049,"source":{"system":"sec-edgar","filing":"0001883850-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000014/edgardoc.xml","form_type":"4"}},{"id":2367049,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-01T21:03:13.000Z","date":"2022-02-25","kind":"sale","acquired":false,"shares":2000,"price":621,"value":1242000.0,"ownership":{"direct":true},"balance_after":28049,"source":{"system":"sec-edgar","filing":"0001883850-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000014/edgardoc.xml","form_type":"4"}},{"id":2445818,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-01-05T21:21:01.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":2707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":2707,"derivative":{"exercise_price":625.6,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":2707},"source":{"system":"sec-edgar","filing":"0001708138-22-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000007/edgardoc.xml","form_type":"4"}},{"id":2445817,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:21:01.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":30049,"source":{"system":"sec-edgar","filing":"0001708138-22-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000007/edgardoc.xml","form_type":"4"}},{"id":2499473,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-23T21:29:06.000Z","date":"2021-11-22","kind":"sale","acquired":false,"shares":1000,"price":660,"value":660000.0,"ownership":{"direct":true},"balance_after":29858,"source":{"system":"sec-edgar","filing":"0001883850-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000012/edgardoc.xml","form_type":"4"}},{"id":2499472,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-23T21:29:06.000Z","date":"2021-11-22","kind":"sale","acquired":false,"shares":1000,"price":655,"value":655000.0,"ownership":{"direct":true},"balance_after":30858,"source":{"system":"sec-edgar","filing":"0001883850-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000012/edgardoc.xml","form_type":"4"}},{"id":2499471,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-23T21:29:06.000Z","date":"2021-11-19","kind":"sale","acquired":false,"shares":1000,"price":655,"value":655000.0,"ownership":{"direct":true},"balance_after":31858,"source":{"system":"sec-edgar","filing":"0001883850-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000012/edgardoc.xml","form_type":"4"}},{"id":2505553,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-18T21:09:19.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":750,"price":650,"value":487500.0,"ownership":{"direct":false,"nature":"by Trust for Son"},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001237899-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000024/edgardoc.xml","form_type":"4"}},{"id":2505552,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-18T21:09:19.000Z","date":"2021-11-18","kind":"sale","acquired":false,"shares":4000,"price":650,"value":2600000.0,"ownership":{"direct":true},"balance_after":32858,"source":{"system":"sec-edgar","filing":"0001237899-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000024/edgardoc.xml","form_type":"4"}},{"id":2505551,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-18T21:09:19.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":2000,"price":660,"value":1320000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 2,000 shares of Company stock on November 16, 2021 at prices ranging from $660.00 to $660.24. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price."}],"balance_after":36858,"source":{"system":"sec-edgar","filing":"0001237899-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000024/edgardoc.xml","form_type":"4"}},{"id":2505550,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-18T21:09:19.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":2000,"price":658.79,"value":1317580.0,"ownership":{"direct":true},"balance_after":38858,"source":{"system":"sec-edgar","filing":"0001237899-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000024/edgardoc.xml","form_type":"4"}},{"id":2505549,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-18T21:09:19.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":2000,"price":650,"value":1300000.0,"ownership":{"direct":true},"balance_after":40858,"source":{"system":"sec-edgar","filing":"0001237899-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000024/edgardoc.xml","form_type":"4"}},{"id":2587298,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-30T20:26:06.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":300,"price":672,"value":201600.0,"ownership":{"direct":false,"nature":"by Trust for Son"},"balance_after":1750,"source":{"system":"sec-edgar","filing":"0001237899-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000020/edgardoc.xml","form_type":"4"}},{"id":2587297,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-30T20:26:06.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":250,"price":670,"value":167500.0,"ownership":{"direct":false,"nature":"by Spouse"},"balance_after":750,"source":{"system":"sec-edgar","filing":"0001237899-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000020/edgardoc.xml","form_type":"4"}},{"id":2587296,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-30T20:26:06.000Z","date":"2021-08-26","kind":"sale","acquired":false,"shares":150,"price":672,"value":100800.0,"ownership":{"direct":false,"nature":"by Spouse"},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001237899-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000020/edgardoc.xml","form_type":"4"}},{"id":2587295,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-30T20:26:06.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":500,"price":675,"value":337500.0,"ownership":{"direct":true},"balance_after":42858,"source":{"system":"sec-edgar","filing":"0001237899-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000020/edgardoc.xml","form_type":"4"}},{"id":2587294,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-30T20:26:06.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":500,"price":670,"value":335000.0,"ownership":{"direct":true},"balance_after":43358,"source":{"system":"sec-edgar","filing":"0001237899-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000020/edgardoc.xml","form_type":"4"}},{"id":2601267,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-17T20:17:03.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":1000,"price":627.5,"value":627500.0,"ownership":{"direct":false,"nature":"by Trust for Son"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 1,000 shares of Company stock on August 16, 2021 at prices ranging from $627.37 to $627.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2021 at each separate price."}],"balance_after":2050,"source":{"system":"sec-edgar","filing":"0001237899-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000016/edgardoc.xml","form_type":"4"}},{"id":2601266,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-17T20:17:03.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":705,"price":630,"value":444150.0,"ownership":{"direct":true},"balance_after":43858,"source":{"system":"sec-edgar","filing":"0001237899-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000016/edgardoc.xml","form_type":"4"}},{"id":2604537,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-13T21:19:30.000Z","date":"2021-08-11","kind":"sale","acquired":false,"shares":300,"price":620,"value":186000.0,"ownership":{"direct":false,"nature":"by Trust for Son"},"balance_after":3050,"source":{"system":"sec-edgar","filing":"0001237899-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000014/edgardoc.xml","form_type":"4"}},{"id":2604536,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-13T21:19:30.000Z","date":"2021-08-13","kind":"sale","acquired":false,"shares":500,"price":620,"value":310000.0,"ownership":{"direct":true},"balance_after":44563,"source":{"system":"sec-edgar","filing":"0001237899-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000014/edgardoc.xml","form_type":"4"}},{"id":2604535,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-13T21:19:30.000Z","date":"2021-08-12","kind":"sale","acquired":false,"shares":1000,"price":611,"value":611000.0,"ownership":{"direct":true},"balance_after":45063,"source":{"system":"sec-edgar","filing":"0001237899-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000014/edgardoc.xml","form_type":"4"}},{"id":2604534,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-13T21:19:30.000Z","date":"2021-08-11","kind":"sale","acquired":false,"shares":1000,"price":621,"value":621000.0,"ownership":{"direct":true},"balance_after":46063,"source":{"system":"sec-edgar","filing":"0001237899-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000014/edgardoc.xml","form_type":"4"}},{"id":2604533,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-13T21:19:30.000Z","date":"2021-08-11","kind":"sale","acquired":false,"shares":1000,"price":620,"value":620000.0,"ownership":{"direct":true},"balance_after":47063,"source":{"system":"sec-edgar","filing":"0001237899-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000014/edgardoc.xml","form_type":"4"}},{"id":2609211,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-10T21:00:34.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":350,"price":612.42,"value":214347.0,"ownership":{"direct":false,"nature":"by Trust for Son"},"balance_after":3350,"source":{"system":"sec-edgar","filing":"0001237899-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000011/edgardoc.xml","form_type":"4"}},{"id":2609210,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-10T21:00:34.000Z","date":"2021-08-10","kind":"sale","acquired":false,"shares":1000,"price":613.01,"value":613010.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 1,000 shares of Company stock on August 10, 2021 at prices ranging from $613.00 to $613.05. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price."}],"balance_after":48063,"source":{"system":"sec-edgar","filing":"0001237899-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000011/edgardoc.xml","form_type":"4"}},{"id":2609209,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-10T21:00:34.000Z","date":"2021-08-10","kind":"sale","acquired":false,"shares":1000,"price":614,"value":614000.0,"ownership":{"direct":true},"balance_after":49063,"source":{"system":"sec-edgar","filing":"0001237899-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000011/edgardoc.xml","form_type":"4"}},{"id":2609208,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-10T21:00:34.000Z","date":"2021-08-10","kind":"sale","acquired":false,"shares":600,"price":615,"value":369000.0,"ownership":{"direct":true},"balance_after":50063,"source":{"system":"sec-edgar","filing":"0001237899-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000011/edgardoc.xml","form_type":"4"}},{"id":2609207,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-10T21:00:34.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":1000,"price":611.23,"value":611230.0,"ownership":{"direct":true},"balance_after":50663,"source":{"system":"sec-edgar","filing":"0001237899-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000011/edgardoc.xml","form_type":"4"}},{"id":2609206,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-10T21:00:34.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":3000,"price":611.43,"value":1834290.0,"ownership":{"direct":true},"balance_after":51663,"source":{"system":"sec-edgar","filing":"0001237899-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000011/edgardoc.xml","form_type":"4"}},{"id":2923400,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-01-05T21:32:23.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":3613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":3613,"derivative":{"exercise_price":482.68,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":3613},"source":{"system":"sec-edgar","filing":"0001237899-21-000003","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000003/edgardoc.xml","form_type":"4"}},{"id":2923399,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:32:23.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":54663,"source":{"system":"sec-edgar","filing":"0001237899-21-000003","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000003/edgardoc.xml","form_type":"4"}},{"id":3044142,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-31T20:36:38.000Z","date":"2020-08-31","kind":"sale","acquired":false,"shares":1900,"price":614.51,"value":1167569.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 1,900 shares of Company stock on August 31, 2020 at prices ranging from $614.01 to $614.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price."}],"balance_after":54415,"source":{"system":"sec-edgar","filing":"0001237899-20-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000038/edgardoc.xml","form_type":"4"}},{"id":3044141,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-31T20:36:38.000Z","date":"2020-08-31","kind":"sale","acquired":false,"shares":1100,"price":613.54,"value":674894.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 1,100 shares of Company stock on August 31, 2020 at prices ranging from $613.00 to $613.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price."}],"balance_after":56315,"source":{"system":"sec-edgar","filing":"0001237899-20-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000038/edgardoc.xml","form_type":"4"}},{"id":3044140,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-31T20:36:38.000Z","date":"2020-08-31","kind":"sale","acquired":false,"shares":2000,"price":612.27,"value":1224540.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 2,000 shares of Company stock on August 31, 2020 at prices ranging from $612.05 to $612.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price."}],"balance_after":57415,"source":{"system":"sec-edgar","filing":"0001237899-20-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000038/edgardoc.xml","form_type":"4"}},{"id":3044139,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-31T20:36:38.000Z","date":"2020-08-31","kind":"sale","acquired":false,"shares":1400,"price":611.38,"value":855932.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 1,400 shares of Company stock on August 31, 2020 at prices ranging from $611.13 to $611.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price."}],"balance_after":59415,"source":{"system":"sec-edgar","filing":"0001237899-20-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000038/edgardoc.xml","form_type":"4"}},{"id":3044138,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-31T20:36:38.000Z","date":"2020-08-31","kind":"sale","acquired":false,"shares":3600,"price":610.45,"value":2197620.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 3,600 shares of Company stock on August 31, 2020 at prices ranging from $610.05 to $610.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price."}],"balance_after":60815,"source":{"system":"sec-edgar","filing":"0001237899-20-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000038/edgardoc.xml","form_type":"4"}},{"id":3045904,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"exercise","acquired":false,"shares":12750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":273.67,"expiration_date":"2024-01-02","underlying":"Common Stock","underlying_shares":12750},"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045903,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":1000,"price":612,"value":612000.0,"ownership":{"direct":false,"nature":"by Trust for Son"},"balance_after":3700,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045902,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":300,"price":614.15,"value":184245.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents volume-weighted average price of sales of 300 shares of Company stock on August 25, 2020 at prices ranging from $614.01 to $614.29. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":64415,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045901,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":800,"price":613.39,"value":490712.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents volume-weighted average price of sales of 800 shares of Company stock on August 25, 2020 at prices ranging from $613.07 to $613.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":64715,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045900,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":1900,"price":612.43,"value":1163617.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents volume-weighted average price of sales of 1,900 shares of Company stock on August 25, 2020 at prices ranging from $612.09 to $612.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":65515,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045899,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":3840,"price":611.6,"value":2348544.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents volume-weighted average price of sales of 3,840 shares of Company stock on August 25, 2020 at prices ranging from $611.14 to $611.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":67415,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045898,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":3793,"price":610.42,"value":2315323.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 3,793 shares of Company stock on August 25, 2020 at prices ranging from $610.00 to $610.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":71255,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045897,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":760,"price":609.67,"value":463349.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 760 shares of Company stock on August 25, 2020 at prices ranging from $609.15 to $609.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":75048,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045896,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":300,"price":608.06,"value":182418.0,"ownership":{"direct":true},"balance_after":75808,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045895,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":2384,"price":607.46,"value":1448184.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 2,384 shares of Company stock on August 25, 2020 at prices ranging from $607.13 to $607.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":76108,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045894,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":5168,"price":606.43,"value":3134030.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 5,168 shares of Company stock on August 25, 2020 at prices ranging from $606.05 to $606.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":78492,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045893,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":4700,"price":605.53,"value":2845991.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 4,700 shares of Company stock on August 25, 2020 at prices ranging from $605.00 to $605.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":83660,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045892,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":3705,"price":604.43,"value":2239413.15,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 3,705 shares of Company stock on August 25, 2020 at prices ranging from $604.00 to $604.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":88360,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045891,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":3000,"price":603.53,"value":1810590.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 3,000 shares of Company stock on August 25, 2020 at prices ranging from $603.02 to $603.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":92065,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045890,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":400,"price":602.68,"value":241072.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 400 shares of Company stock on August 25, 2020 at prices ranging from $602.05 to $602.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":95065,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045889,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":300,"price":601.75,"value":180525.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 300 shares of Company stock on August 25, 2020 at prices ranging from $601.64 to $601.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":95465,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045888,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":1400,"price":600.36,"value":840504.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 1,400 shares of Company stock on August 25, 2020 at prices ranging from $600.04 to $600.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price."}],"balance_after":95765,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3045887,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T20:23:04.000Z","date":"2020-08-25","kind":"exercise","acquired":true,"shares":12750,"price":273.67,"value":3489292.5,"ownership":{"direct":true},"balance_after":97165,"source":{"system":"sec-edgar","filing":"0001708138-20-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000102/edgardoc.xml","form_type":"4"}},{"id":3049157,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-08-24T22:14:12.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":10037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Form two of two"}],"balance_after":0,"derivative":{"exercise_price":177.82,"expiration_date":"2023-01-02","underlying":"Common Stock","underlying_shares":10037},"source":{"system":"sec-edgar","filing":"0001708138-20-000098","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000098/edgardoc.xml","form_type":"4"}},{"id":3049156,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-08-24T22:14:12.000Z","date":"2020-08-21","kind":"exercise","acquired":false,"shares":4963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":10037,"derivative":{"exercise_price":177.82,"expiration_date":"2023-01-02","underlying":"Common Stock","underlying_shares":4963},"source":{"system":"sec-edgar","filing":"0001708138-20-000098","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000098/edgardoc.xml","form_type":"4"}},{"id":3049155,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-08-24T22:14:12.000Z","date":"2020-08-21","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":57.11,"expiration_date":"2022-01-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001708138-20-000098","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000098/edgardoc.xml","form_type":"4"}},{"id":3049154,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-08-24T22:14:12.000Z","date":"2020-08-20","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":57.11,"expiration_date":"2022-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001708138-20-000098","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000098/edgardoc.xml","form_type":"4"}},{"id":3049153,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70164,"kind":"person","name":"SING GEORGE L","position":1,"cik":"0001225471","reported_name":"SING GEORGE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-24T22:13:45.000Z","date":"2020-08-24","kind":"sale","acquired":false,"shares":136,"price":593.23,"value":80679.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F25","text":"Represents volume-weighted average price of sales of 136 shares of Company stock on August 24, 2020 at prices ranging from $593.06 to $593.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2020 at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F26","text":"Form one of two"}],"balance_after":84415,"source":{"system":"sec-edgar","filing":"0001708138-20-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000097/edgardoc.xml","form_type":"4"}}],"next_cursor":"2020-08-24T22:13:45.000000Z,3049153"}